GENEDRIVE PLC Logo

GENEDRIVE PLC

Develops rapid, point-of-care pharmacogenetic testing platforms for personalized medicine.

GDR | IL

Overview

Corporate Details

ISIN(s):
GB00B1VKB244 (+2 more)
LEI:
213800ZYODIRZ87Y4K14
Country:
United Kingdom
Address:
THE INCUBATOR BUILDING, M13 9XX MANCHESTER

Description

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 10:10
New interactive investor hub
English 13.8 KB
2025-12-09 17:00
Agreement of Shareholder Loan
English 16.9 KB
2025-12-08 17:10
Annual Report and Accounts and date of AGM
English 13.1 KB
2025-12-05 08:20
Final Results
English 215.8 KB
2025-12-03 08:35
Notice of Results
English 13.7 KB
2025-12-01 16:30
Block Listing Returns
English 24.2 KB
2025-12-01 08:40
Results presented re. NHS CYP2C19 Genotype Testing
English 20.0 KB
2025-11-27 11:20
NHS implementation guide published for CYP2C19
English 16.9 KB
2025-11-26 08:25
Scotland national roll-out of MT-RNR1 ID Kit
English 15.3 KB
2025-11-19 08:25
Further re Shareholder Loan
English 17.3 KB
2025-11-04 08:30
MT-RNR1 ID Kit in Dublin’s Rotunda Hospital
English 14.8 KB
2025-10-31 08:00
Potential Shareholder Loan
English 13.2 KB
2025-10-24 17:30
Application for Listing & Total Voting Rights
English 12.6 KB
2025-10-10 14:32
Holding(s) in Company
English 52.5 KB
2025-10-10 14:31
Holding(s) in Company
English 23.9 KB

Automate Your Workflow. Get a real-time feed of all GENEDRIVE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENEDRIVE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENEDRIVE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biopharmaceutical firm developing cannabinoid-based medicines for inflammatory conditions.
United Kingdom
ANAN
Designs, develops, and manufactures molecular diagnostic solutions and instruments.
Türkiye
ANGEN
ANAVEX LIFE SCIENCES CORP. Logo
Clinical-stage biopharmaceutical company developing therapeutics for CNS disorders.
United States of America
AVXL
Anbio Biotechnology Logo
Develops and provides in-vitro diagnostic (IVD) solutions and instruments.
United States of America
NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing therapies for acute cannabinoid intoxication.
United States of America
ANEB
AnGes, Inc. Logo
Biopharmaceutical firm developing gene-based and nucleotide-based medicines.
Japan
4563
Anika Therapeutics, Inc. Logo
A global joint preservation company developing solutions for orthopedic care.
United States of America
ANIK
ANIMALCARE GROUP PLC Logo
Develops and commercializes veterinary pharmaceutical products and services globally.
United Kingdom
ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded, generic, and OTC pharmaceutical products.
United States of America
ANIP
Annexin Pharmaceuticals AB Logo
Clinical-stage biotech developing a cell-protecting biologic for RVO and oncology.
Sweden
ANNX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.